COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors (BCLS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03257670
Recruitment Status : Unknown
Verified March 2018 by James Whiteside, University of Cincinnati.
Recruitment status was:  Recruiting
First Posted : August 22, 2017
Last Update Posted : March 27, 2018
Syneron Candela
Information provided by (Responsible Party):
James Whiteside, University of Cincinnati

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 1, 2018
Estimated Study Completion Date : November 1, 2018